13F Portfolios

Davern Capital Partners, LP: ROIVANT SCIENCES LTD (ROIV): Quarterly 13F Position History

As of Q2 2026, Davern Capital Partners, LP reported 1,932,904 shares of ROIVANT SCIENCES LTD (ROIV), worth $68.4M and representing 11.7% of its 13F equity book. Quarter-over-quarter share count change: + 1,059,506 (+121.3%) . The position first appeared in Q4 2025 and has been disclosed across 3 13F-HR filings in Pactolio's tracked window.

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 3 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q2 2026 1,932,904 +1,059,506 +121.3% $68.4M 11.7% $35.4
Q1 2026 873,398 154,900 -15.1% $24.2M 6.6% $27.7
Q4 2025 1,028,298 $22.3M 7.2% $21.7

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.

When did Davern Capital Partners, LP first disclose a ROIV position in 13F-HR filings?

Davern Capital Partners, LP first reported ROIVANT SCIENCES LTD (ROIV) on its 13F-HR filing for the period ending 2025-12-31 (Q4 2025). The position has appeared on 3 reported quarters within Pactolio's tracked window.

What was Davern Capital Partners, LP's most recent quarter-over-quarter share-count change in ROIV?

Between Q1 2026 and Q2 2026, Davern Capital Partners, LP added 1,059,506 shares of ROIV (+121.3%), bringing the total reported position to 1,932,904 shares at a market value of $68.4M.

Does the implied price-per-share represent Davern Capital Partners, LP's cost basis in ROIV?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.